(People's Daily health client reporter Wang Zhenya)
According to the information reported by the People's Daily health client reporter, hainan, Tibet, Liaoning, Fujian, Shandong, Liaoning and other places have issued the specific implementation time of the sixth batch of national collection (insulin special project), which is in May.
Collection of drugs window, picture from Xinhua News Agency.
On April 20, the Liaoning Provincial Medical Insurance Bureau issued a notice that Liaoning Province will begin to implement the results of the sixth batch of national collective collection (insulin special) winning bids on May 15. On April 19, the Tibet Autonomous Region Medical Insurance Bureau issued a notice that the sixth batch of nationally collected drugs in Tibet will be implemented on May 1.
"The policy is to require that the insulin collection program be implemented in May. We will also do it according to national policy. Deng Guiming, chief pharmacist of the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, told reporters that this is the first time that the country has collected insulin, and after the collection, the price of insulin has dropped a lot, and if it is implemented in May, patients can get insulin after the price reduction when they go to the hospital to prescribe drugs.
For example, insulin aspart 30 injection is about 75 yuan before collection and 43.2 yuan after collection; insulin glargine injection is about 140 yuan before collection, and the daily expenditure of patients is 7-14 yuan, and after collection is 48.71 yuan.
According to the data of the Medical Insurance Bureau, the procurement demand of medical institutions nationwide in the first year was about 210 million, and the sixth collection involved a procurement amount of about 17 billion yuan. The results of the sixth batch of national mining (insulin special) selection show that the average price of the winning products was reduced by 48%, and the highest reduction was more than 70%, of which Eli Lai's sperm protein zinc recombinant lispro mixed injection had the largest decline, more than 73%. Gan&Lee Pharmaceutical's insulin aspart injection decreased by more than 72%.
Recently, many diabetics are looking forward to the results of insulin collection. Yang Jing, deputy chief physician of endocrinology at the First Affiliated Hospital of the University of South China, told the People's Daily health client reporter that recently many sugar friends have asked whether the next time they come to get medicine is insulin cheaper.
Although the specific landing time has not yet been released in some areas, it can be seen that the landing work is being carried out in an orderly manner through the relevant documents issued by the local medical insurance bureaus. Tao Hong, chief physician of endocrinology at Beijing Anzhen Hospital, told the People's Daily health client reporter that at present, Beijing Hospital has not received relevant notices, and the specific implementation time may be after May Day.